IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism
Interleukin (IL)-19, a member of the IL-10 family, is an anti-inflammatory cytokine produced primarily by macrophages. Nonalcoholic steatohepatitis (NASH) is a disease that has progressed from nonalcoholic fatty liver disease (NAFLD) and is characterized by inflammation and fibrosis. We evaluated th...
Main Authors: | Yasu-Taka Azuma, Takashi Fujita, Takeshi Izawa, Kana Hirota, Kazuhiro Nishiyama, Airi Ikegami, Tomoko Aoyama, Mikihito Ike, Yumi Ushikai, Mitsuru Kuwamura, Hideki Fujii, Koichi Tsuneyama |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/12/3513 |
Similar Items
-
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis
by: Kristine Griffett, et al.
Published: (2015-04-01) -
MicroRNAs and Nonalcoholic Steatohepatitis: A Review
by: Asahiro Morishita, et al.
Published: (2023-09-01) -
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01) -
Cardiac dysfunction in a cohort of biopsy proven nonalcoholic steatohepatitis in comparison to nonalcoholic fatty liver
by: Jijo Varghese, et al.
Published: (2023-01-01) -
Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Young-Su Yi
Published: (2024-03-01)